承董事會命 中國人民保險集團股份有限公司 丁向群 董事長 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 1339 董事會會議通知 中國人民保險集團股份有限公司（「本公司」）董事會（「董事會」）茲通告謹定於二零二五年 四月二十九日（星期二）舉行董事會會議，以審議及批准本公司及其附屬公司截至二零二 五年三月三十一日止三個月的第一季度未經審核業績及其刊發，並處理任何其他事項。 中國北京，二零二五年四月十五日 於本公告日，本公司執行董事為丁向群女士、趙鵬先生及肖建友先生，非執行董事為王 清劍先生、苗福生先生、王少群先生、喻強先生及宋洪軍先生，獨立非執行董事為邵善 波先生、徐麗娜女士、王鵬程先生及高平陽先生。 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) with a target price of RMB 8.10 and HKD 4.90 [8][9]. Core Views - The company expects a year-on-year increase in net profit of 30% to 50% for Q1 2025, driven by improved underwriting profits and significant growth in investment income [1]. - The property insurance sector is benefiting from a decrease in disasters, leading to a lower combined ratio (COR) estimated at 97.1% for 2025 [2]. - The life insurance segment is projected to see a stable growth in new business value (NBV) with an expected growth rate of 17% in 2025 [3]. - The company's investment performance has significantly improved due to optimized asset allocation, resulting in substantial investment income growth in Q1 2025 [4]. - The earnings per share (EPS) forecasts for 2025, 2026, and 2027 have been raised to RMB 1.02, RMB 0.93, and RMB 1.01 respectively, reflecting a positive outlook on underwriting profits and investment performance [5]. Summary by Sections Property Insurance - The property insurance sector has shown improved underwriting performance, with a decrease in claims ratio due to fewer disasters, leading to a projected COR of approximately 97.1% for 2025 [2]. Life Insurance - The life insurance sector has experienced a slight decline in premium income by 2.6% year-on-year, but this is expected to mitigate risks associated with interest spread losses. The NBV is anticipated to grow by 17% in 2025 [3]. Investment Performance - The company has optimized its investment portfolio, with a significant increase in investment income in Q1 2025. The asset allocation includes 11% cash, 49% bonds, 14% equities, and 15% non-standard investments [4]. Earnings Forecast and Valuation - The company has adjusted its EPS forecasts upwards for 2025, 2026, and 2027, with target prices set at RMB 8.10 and HKD 4.90 based on DCF valuation methods [5].

Company Overview - The company ranked 158th in the 2024 Fortune Global 500 list[5]. - The company holds approximately 68.98% of the shares in PICC Property and Casualty, which operates property insurance in mainland China[6]. - The company directly and indirectly holds 80.00% of PICC Life Insurance, which operates life insurance and health insurance businesses[6]. - The company has a robust management team supported by experienced shareholders and a high-quality professional talent pool[7]. - The company is committed to sustainable development and fulfilling its social responsibilities[7]. Financial Performance - Total assets reached CNY 1,766.32 billion, an increase of 13.5% compared to CNY 1,556.68 billion in 2023[17]. - Net profit for 2024 was CNY 56.78 billion, representing an 84.3% increase from CNY 30.81 billion in 2023[18]. - Insurance service revenue grew to CNY 537.71 billion, up 6.7% from CNY 503.90 billion in 2023[20]. - The weighted average return on equity increased to 16.4%, up 7.0 percentage points from 9.4% in 2023[17]. - Original insurance premium income reached CNY 2,693.02 billion, a 4.7% increase year-on-year[20]. - Total investment income was CNY 82.16 billion, reflecting an 86.2% increase year-on-year[22]. - The group reported a net profit attributable to shareholders of CNY 42.15 billion in 2024, marking an impressive year-on-year increase of 88.8%[48]. - The group’s total revenue for 2024 was CNY 622.22 billion, a 12.4% increase from CNY 553.47 billion in 2023[57]. Investment and Asset Management - The company has a strong asset management platform with a solid investment performance and a conservative investment style[7]. - Investment assets exceeded CNY 16 trillion, growing by 14.6% from the beginning of the year[20]. - The scale of managed assets grew to CNY 3.6 trillion, up 16.7% year-on-year[38]. - The investment portfolio as of December 31, 2024, totaled CNY 1,641.756 billion, with fixed income investments accounting for 67.9% of the total[117]. - The total investment yield for 2024 was 5.6%, up by 2.3 percentage points year-on-year[123]. Digital Transformation and Technology - The company emphasizes digital transformation through its subsidiary PICC Technology, which provides data empowerment and smart technology services[6]. - The company has established a technology insurance product library and signed the first batch of major technology breakthrough insurance, covering 31 trillion yuan in insurance liabilities for 120,000 high-tech enterprises and 67,000 specialized and innovative enterprises[25]. - The company has accelerated digital construction, focusing on building a unified technological foundation across six key areas, enhancing its core technological competitiveness[32]. - The company achieved an operating revenue of CNY 622.2 billion, representing a year-on-year growth of 12.4%[38]. Risk Management - The group maintains sufficient solvency and effective execution of risk preferences, with ongoing improvements in revenue-cost matching[143]. - The group has established a comprehensive risk management system, focusing on organizational structure transparency and risk assessment, with semi-annual reports to senior management and the board[145]. - The company has implemented an intelligent risk control platform to enhance risk monitoring and early warning capabilities, which won a first-class award from the People's Bank of China[141]. - The group emphasizes liquidity risk management, conducting regular assessments and enhancing cash flow monitoring to maintain a reasonable liquidity level[149]. Health and Agricultural Insurance - The company is focused on expanding its health insurance services, being the first national professional health insurance company in China[7]. - The company has provided risk protection of 2.1 trillion yuan for 55.42 million agricultural households through agricultural insurance, including a new insurance product for agricultural seed quality resources[25]. - Agricultural insurance service revenue reached CNY 55.466 billion, a year-on-year increase of 4.9%[69]. - The health insurance segment achieved original premium income of CNY 48.70 billion, a year-on-year increase of 7.7%, with first-year premium income growing by 50.2%[51]. Customer Satisfaction and Market Position - The company has improved customer satisfaction, with net promoter scores increasing by 6.0%, 4.4%, and 6.0% for property, life, and health insurance respectively[31]. - The group maintained a market share of 31.8% in the property insurance market as of December 31, 2024[48]. - The company plans to leverage opportunities from national policies to enhance its operational effectiveness and achieve high-quality development in 2025[40]. Future Outlook and Strategic Goals - The company aims to leverage its competitive advantages in the insurance sector to support national strategies and economic stability[7]. - The group is focused on building a world-class insurance financial group with five key development goals[41]. - The company anticipates macroeconomic risks, including international uncertainties and domestic economic challenges, but expects steady progress due to policy support[155]. - The group plans to deepen reforms and promote high-quality development in alignment with national modernization goals[44].

Group 1: Macroeconomic Insights - In March 2025, exports increased significantly with a year-on-year growth rate of 12.4%, up from 2.3% in January-February, surpassing Bloomberg's consensus estimate of 4.6% [2] - The trade surplus for March reached $102.6 billion, contributing to a cumulative trade surplus of nearly 2 trillion RMB in the first quarter, which is an increase of approximately 600 billion RMB year-on-year [2] - The estimated contribution of external demand to actual GDP growth is projected to be 2.9 percentage points, potentially pushing the actual GDP year-on-year growth rate to 5% or higher [2] Group 2: Market Trends and Fund Flows - In the A-share market, there was a net outflow of financing funds close to 100 billion RMB last week, but the financing balance stabilized in the latter half of the week, indicating a potential market reversal [3] - The week saw significant inflows into broad-based ETFs, with net inflows reaching a record high since 2018, driven by institutional announcements of increased holdings [3] - The scale of share buybacks and capital increases reached new highs for 2025, indicating strong support for market stabilization [3] Group 3: Real Estate Sector Analysis - In 2024, the overall performance of domestic real estate companies was under pressure, with declines in both sales and land acquisition amounts, but the industry concentration increased, showing resilience among leading firms [12] - The main theme for 2025 is expected to be "steady operation and focus on core business," with a strategy of "sales-driven investment" to revitalize old inventory [12] - There is an anticipated increase in the proportion of operating profits for some real estate companies, alongside a continuous push for product quality upgrades [12] Group 4: Lithium Battery Materials Outlook - In 2024, capital expenditures for most lithium battery material companies declined year-on-year, with significant changes in supply-demand dynamics and profitability [13] - The report forecasts a tightening supply-demand situation for lithium iron phosphate and lithium hexafluorophosphate in the second half of 2025, leading to potential price increases [13] - Companies with cost or technological advantages in the supply chain are expected to see improvements in market share and profitability [13] Group 5: Company-Specific Performance - Shanghai Construction Group reported a revenue of 300.2 billion RMB for 2024, a slight decline of 1.45% year-on-year, but net profit increased by 39.2% [14] - Net profit for Guoyuan Securities reached 2.244 billion RMB in 2024, a year-on-year increase of 20%, driven by a 123% increase in investment income [15] - Net profit for NetEase Technology in 2024 was 675 million RMB, reflecting a 10.02% year-on-year increase, with expectations for accelerated growth in 2025 due to AI applications [15]

Core Insights - The total compensation for executives in five A-share listed insurance companies has decreased for six consecutive years, with a nearly 12% year-on-year decline in 2024 [1][3] - There is a notable divergence in the compensation trends among leading insurance companies, with New China Life Insurance seeing a significant increase in executive compensation, while others like China Pacific Insurance and China Life Insurance experienced varying degrees of decline [1][3] Summary by Category Executive Compensation Trends - The total compensation for executives in New China Life Insurance rose by 27.9% to 1681.4 million yuan in 2024, while China Pacific Insurance saw the largest drop of 35.85%, with total compensation falling to 2280.7 million yuan [2][3][6] - The proportion of executives earning less than 500,000 yuan increased, with 33.33% of executives earning below this threshold in 2024, up 2.42 percentage points from 2023 [3] Market and Regulatory Influences - The decline in executive compensation is attributed to regulatory controls on short-term incentives and a proactive approach by insurance companies to manage future risks [3][4] - The insurance industry is shifting towards compressing short-term incentives and implementing mechanisms like deferred payments and clawbacks to align executive compensation with long-term risk management [7][8] Performance Metrics - Despite a 77.7% year-on-year increase in net profit for the five major insurance companies, executive compensation has not rebounded, indicating a complex interplay between regulatory guidance and market-driven incentives [7] - The regulatory framework encourages a balance between short-term and long-term performance metrics, aiming to foster sustainable growth within the insurance sector [8]

Investment Rating - The industry investment rating is "Overweight" indicating a positive outlook for the non-banking financial sector relative to the broader market [6][36]. Core Insights - The report highlights that the recent adjustments in insurance capital investment regulations are expected to provide additional funding to the equity market, enhancing market confidence and creating investment opportunities [4][6]. - The performance of brokerage firms is anticipated to improve due to increased trading activity and favorable quarterly earnings forecasts, with significant profit growth reported by several major firms [6][10]. - The insurance sector is poised for growth as regulatory changes allow for higher equity investment limits, potentially injecting around 1 trillion yuan into the market [6][34]. Summary by Sections Market Review - The non-banking financial index fell by 5.2% last week, underperforming the CSI 300 index by 2.3 percentage points, with both brokerage and insurance indices showing declines of 5.4% and 4.7% respectively [6][10]. - Average daily trading volume in the stock market reached 19,722 billion yuan, a week-on-week increase of 41.9% [19]. Brokerage Insights - The report emphasizes the recovery of market confidence driven by long-term capital inflows and the proactive measures taken by major funds, including share buybacks and shareholder increases [6]. - Major brokerages reported substantial profit growth for Q1 2025, with East Wu Securities showing a year-on-year increase of 100%-120% [6][10]. Insurance Insights - Recent regulatory changes have raised the equity investment limits for insurance funds, potentially leading to an influx of approximately 1 trillion yuan into the equity market [6][34]. - The report notes that China Life Insurance expects a 30%-50% increase in net profit for Q1 2025, driven by improved liability structure and investment returns [6]. Investment Recommendations - For brokerages, the report suggests focusing on firms with strong capital positions and stable operations, particularly in the context of mergers and acquisitions [6]. - In the insurance sector, attention is drawn to large comprehensive insurance companies that possess competitive advantages under the new regulatory framework [6].

金十图示：2025年04月14日（周一）富时中国A50指数成分股今日收盘行情一览：石油、煤炭板块走强，家电行业偏软 保险 队 中国人保 中国太保 中国平安 001 3002,81亿市值 2911.12亿市值 9010.42亿市值 19.22亿成交额 7.36亿成交额 8.14亿成交额 30.26 49.48 6.79 +0.12(+0.40%) +0.13(+0.26%) +0.23(+3.51%) 酸酒行业 贵州茅台 五粮液 山西汾酒 19496.06亿市值 2631.46亿市值 5086.46亿市值 16.55亿成交额 33.79亿成交额 11.18亿成交额 1551.99 215.70 131.04 -5.29(-2.39%) -16.99(-1.08%) -0.56(-0.43%) 半导体 北方华创 寒武纪-U 海光信息 HYGON 2442.60亿市值 2662.12亿市值 3489.99亿市值 32.08亿成交额 19.55亿成交额 55.42亿成交额 150.15 457.50 637.70 +3.23(+2.20%) 0.00(0.00%) +22.72(+3.69%) 汽车整车 铁路公路 比 ...

Group 1: Company Announcements - China Pacific Insurance (China Life) expects a net profit increase of 30% to 50% for Q1 2025, projecting a profit range of 11.652 billion to 13.445 billion yuan [2] - New Lai Fu plans to acquire 100% equity of Guangzhou Jin Nan Magnetic Materials, with trading suspension starting from April 14, 2025, due to significant asset restructuring [3] - Jiangling Motors intends to repurchase A-shares with a total fund of no less than 1.5 billion and no more than 2 billion yuan, at a price not exceeding 22.00 yuan per share [4] - Guanghua Technology anticipates a net profit increase of 479.25% to 637.23% for Q1 2025, estimating a profit range of 22 million to 28 million yuan [7] - Starhua New Materials reported a net profit of 148 million yuan for 2024, with a year-on-year increase of 51.93%, and plans to distribute a cash dividend of 8 yuan per 10 shares [10] Group 2: Clinical Trial Approvals - Heng Rui Pharmaceutical received approval for clinical trials of HRS-9190, a new drug for anesthesia, and SHR-3792, an innovative anti-tumor candidate, with no similar drugs approved in the market [1]

Group 1: Company Performance - Guanghua Technology expects a net profit growth of 479% to 637% year-on-year for Q1 2025, with an estimated profit of 22 million to 28 million yuan, driven by business expansion in specialized chemicals and cost reduction measures [1] - China Pacific Insurance anticipates a net profit increase of 30% to 50% year-on-year for Q1 2025, projecting a profit of 11.652 billion to 13.445 billion yuan, attributed to improved business quality and significant investment performance [2] - Zhenyu Technology forecasts a net profit growth of 31.54% to 42.97% year-on-year for Q1 2025, estimating a profit of 69 million to 75 million yuan, supported by increased sales orders and enhanced production automation [7] - Chuangjiang New Materials expects a net profit increase of 26.74% to 46.24% year-on-year for Q1 2025, with an estimated profit of 130 million to 150 million yuan, driven by stable growth in production and sales [8] Group 2: Corporate Actions - Xinlaifu plans to acquire 100% equity of Guangzhou Jinnan Magnetic Materials, leading to a significant asset restructuring, with trading suspended from April 14, 2025 [2] - Jiangling Motors intends to repurchase A-shares worth 150 million to 200 million yuan for employee stock ownership plans or equity incentives [5] - Yingfeite plans to repurchase shares worth 50 million to 100 million yuan for employee stock ownership or equity incentive plans [6] - Guanghua Technology's major shareholder is undergoing a change in its upper equity structure, but the actual controller remains the Zhuhai State-owned Assets Supervision and Administration Commission [4] Group 3: Regulatory Approvals - Hengrui Medicine received approval for clinical trials of its new drug HRS-9190, which is intended for use during anesthesia induction and maintenance [9]

Financial Performance - The estimated net profit attributable to the parent company's shareholders for Q1 2025 is expected to be between RMB 11.652 billion and RMB 13.445 billion, an increase of RMB 2.689 billion to RMB 4.482 billion compared to the same period last year, representing a year-on-year growth of 30% to 50%[2] - The estimated net profit attributable to the parent company's shareholders, excluding non-recurring gains and losses, is expected to be between RMB 11.606 billion and RMB 13.392 billion, with a similar increase of RMB 2.678 billion to RMB 4.464 billion year-on-year, also reflecting a growth of 30% to 50%[3] - The net profit for the same period last year was RMB 8.963 billion, with a total profit of RMB 13.849 billion[4] - The earnings per share for the same period last year was RMB 0.20[5] Factors Influencing Profit Growth - The main reasons for the profit increase include the implementation of national financial policies, innovation in insurance products, and a focus on long-term and value investments in the capital market[6] - The company emphasizes the importance of optimizing business structure and improving business quality, leading to rapid growth in underwriting performance[6] Forecast Accuracy - The company has no significant uncertainties that could affect the accuracy of this profit forecast[7] - The data provided is preliminary and subject to final confirmation in the official Q1 2025 report[8]